Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells

Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification

(2012) Karine Breckpot et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Lentiviral Vectors Targeted to MHC II Are Effective in Immunization

(2011) Alexander Ageichik et al.   HUMAN GENE THERAPY

Measles Virus Glycoprotein-Pseudotyped Lentiviral Vector-Mediated Gene Transfer into Quiescent Lymphocytes Requires Binding to both SLAM and CD46 Entry Receptors

(2011) C. Frecha et al.   JOURNAL OF VIROLOGY

Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential

(2010) David Escors et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types

(2010) K. De Groeve et al.   JOURNAL OF NUCLEAR MEDICINE

HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7

(2010) K. Breckpot et al.   JOURNAL OF VIROLOGY

Advances in the Field of Lentivector-based Transduction of T and B Lymphocytes for Gene Therapy

(2010) Cecilia Frecha et al.   MOLECULAR THERAPY

Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus

(2010) Xian-Yang Zhang et al.   Retrovirology

Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors

(2009) C. Frecha et al.   BLOOD

Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity

(2009) S Funke et al.   GENE THERAPY

Single-Chain Antibodies That Target Lentiviral Vectors to MHC Class II on Antigen-Presenting Cells

(2009) Francesca Gennari et al.   HUMAN GENE THERAPY

Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins

(2008) C. Frecha et al.   BLOOD

Lentiviral Vectors for Anti-Tumor Immunotherapy

(2008) Karine Breckpot et al.   CURRENT GENE THERAPY

Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission

(2008) Marleen Keyaerts et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Targeting Lentiviral Vectors to Antigen-Specific Immunoglobulins

(2008) Leslie Ziegler et al.   HUMAN GENE THERAPY

General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold

(2008) Cécile Vincke et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Engineered lentivector targeting of dendritic cells for in vivo immunization

(2008) Lili Yang et al.   NATURE BIOTECHNOLOGY